NCT02918357 · OUTCOME
Sensitivity on a Per-region Basis
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of sensitivity
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 1 month
What was measured
Sensitivity, on a per-region basis of 68Ga-PSMA-11 PET for detection of tumor location confirmed by histopathology/biopsy was calculated. The 95% CI was calculated using the Wilson score method.
Analysis population: Eighty-four patients had confirmed histopathology region validation for this analysis
Groups in this outcome
Ga-68 Labeled PSMA-11 PET
PSMA PET imaging: Patients will receive Ga-68 labeled PSMA-11 PET and then undergo PET/CT or PET/MRI approximately 55-70 minutes later. Ga-68 labeled PSMA-11 PET: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.
| Group | Source count |
|---|---|
| Ga-68 Labeled PSMA-11 PET | 84 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Ga-68 Labeled PSMA-11 PET | 0.90 | Not reported | 0.82 | 0.95 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.82
- upper Limit
- 0.95
- value
- 0.90
- denoms
- counts
- group Id
- OG000
- value
- 84
- units
- Participants
- description
- Sensitivity, on a per-region basis of 68Ga-PSMA-11 PET for detection of tumor location confirmed by histopathology/biopsy was calculated. The 95% CI was calculated using the Wilson score method.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- PSMA PET imaging: Patients will receive Ga-68 labeled PSMA-11 PET and then undergo PET/CT or PET/MRI approximately 55-70 minutes later. Ga-68 labeled PSMA-11 PET: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.
- id
- OG000
- title
- Ga-68 Labeled PSMA-11 PET
- param Type
- NUMBER
- population Description
- Eighty-four patients had confirmed histopathology region validation for this analysis
- reporting Status
- POSTED
- time Frame
- 1 month
- title
- Sensitivity on a Per-region Basis
- type
- SECONDARY
- unit Of Measure
- percentage of sensitivity
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle